Prostate Cancer News & Features

IMRT offers no significant benefit over CRT following prostatectomy

IMRT offers no significant benefit over CRT following prostatectomy

No significant difference in morbidity, cancer control for men treated post-prostatectomy using Intensity-modulated radiotherapy (IMRT) over conformal radiotherapy (CRT).

Sleep problems may increase risk for prostate cancer

Men who reported sleep problems, including difficulty falling asleep and staying asleep, had up to a twofold increased risk for prostate cancer, according to recently published data.

Prostate cancer comorbidities increase other-cause death risk for men

Prostate cancer comorbidities increase other-cause death risk for men

For older men with nonmetastatic prostate cancer, comorbidities increase risk of other-cause death mortality.

Statin use may reduce deaths from prostate cancer

Men with prostate cancer who used statin drugs prior to diagnosis had a decreased risk of prostate-cancer-specific mortality.

ASCO: Midlife fitness may protect against lung cancer

ASCO: Midlife fitness may protect against lung cancer

High fitness has been linked to reductions in risk of developing and dying from lung, colorectal cancer.

New prostate cancer test improve risk assessment

A new tool helps identify men who are best suited for active surveillance of prostate cancer, predicting which are more likely to harbor an aggressive form of the disease.

Prostate cancer risk higher for obese men even after benign biopsy

Obese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with nonobese men, and they were at a greater risk for subsequently developing prostate cancer, according to a new study.

FDA approves Xofigo for advanced prostate cancer treatment

The FDA has approved Xofigo (radium Ra 223 dichloride; Bayer) for the treatment of symptomatic late-stage castration-resistant prostate cancer with bone metastases.

Surgeon Variation Affects QoL After Prostatectomy

Surgeon Variation Affects QoL After Prostatectomy

Significant associations seen in men's urinary and sexual function based on surgeon performing radical prostatectomy.

Certain DNA changes linked to development and lethality of prostate cancer

A new analysis has found that the loss or amplification of particular DNA regions contributes to the development of prostate cancer, and that patients with two of these DNA changes have a high likelihood of dying from the disease.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs